Puma Biotechnology Inc (PBYI): Are Hedge Funds Right About This Stock? – Exelixis, Inc. (EXEL), NPS Pharmaceuticals, Inc. (NPSP)

Is Puma Biotechnology Inc (NYSE:PBYI) going to take off soon? Prominent investors are becoming hopeful. The number of long hedge fund bets improved by 9 in recent months.

Puma Biotechnology Inc

In the eyes of most market participants, hedge funds are viewed as unimportant, old financial vehicles of years past. While there are over 8000 funds trading at the moment, we look at the upper echelon of this group, around 450 funds. It is widely believed that this group has its hands on the majority of the hedge fund industry’s total capital, and by watching their best equity investments, we have spotted a number of investment strategies that have historically beaten the S&P 500 index. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have outpaced the S&P 500 index by 24 percentage points in 7 months (check out a sample of our picks).

Equally as beneficial, optimistic insider trading activity is a second way to break down the stock market universe. As the old adage goes: there are lots of incentives for a corporate insider to get rid of shares of his or her company, but only one, very clear reason why they would behave bullishly. Many academic studies have demonstrated the valuable potential of this method if shareholders understand where to look (learn more here).

Consequently, it’s important to take a peek at the latest action encompassing Puma Biotechnology Inc (NYSE:PBYI).

How are hedge funds trading Puma Biotechnology Inc (NYSE:PBYI)?

At the end of the fourth quarter, a total of 11 of the hedge funds we track held long positions in this stock, a change of 450% from one quarter earlier. With hedgies’ sentiment swirling, there exists an “upper tier” of notable hedge fund managers who were increasing their holdings substantially.

Of the funds we track, Adage Capital Management, managed by Phill Gross and Robert Atchinson, holds the largest position in Puma Biotechnology Inc (NYSE:PBYI). Adage Capital Management has a $98.3 million position in the stock, comprising 0.4% of its 13F portfolio. Sitting at the No. 2 spot is Samuel Isaly of OrbiMed Advisors, with a $15.9 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Other peers that are bullish include Bain Capital’s Brookside Capital, Steven Cohen’s SAC Capital Advisors and Dmitry Balyasny’s Balyasny Asset Management.

Now, key hedge funds have jumped into Puma Biotechnology Inc (NYSE:PBYI) headfirst. OrbiMed Advisors, managed by Samuel Isaly, assembled the most valuable position in Puma Biotechnology Inc (NYSE:PBYI). OrbiMed Advisors had 15.9 million invested in the company at the end of the quarter. Steven Cohen’s SAC Capital Advisors also initiated a $9.4 million position during the quarter. The other funds with brand new PBYI positions are Dmitry Balyasny’s Balyasny Asset Management, Sean Cullinan’s Point State Capital, and Jacob Gottlieb’s Visium Asset Management.

How have insiders been trading Puma Biotechnology Inc (NYSE:PBYI)?

Insider buying is particularly usable when the primary stock in question has seen transactions within the past six months. Over the last half-year time frame, Puma Biotechnology Inc (NYSE:PBYI) has experienced 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also examine hedge fund and insider activity in other stocks similar to Puma Biotechnology Inc (NYSE:PBYI). These stocks are Exelixis, Inc. (NASDAQ:EXEL), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), PDL BioPharma Inc. (NASDAQ:PDLI), Celldex Therapeutics, Inc. (NASDAQ:CLDX), and MannKind Corporation (NASDAQ:MNKD). All of these stocks are in the biotechnology industry and their market caps resemble PBYI’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Exelixis, Inc. (NASDAQ:EXEL) 10 1 0
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) 18 1 5
PDL BioPharma Inc. (NASDAQ:PDLI) 14 0 0
Celldex Therapeutics, Inc. (NASDAQ:CLDX) 12 0 0
MannKind Corporation (NASDAQ:MNKD) 8 2 0

With the returns demonstrated by the aforementioned tactics, everyday investors must always pay attention to hedge fund and insider trading activity, and Puma Biotechnology Inc (NYSE:PBYI) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!